Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group.

Compared with the expected background incidence (16.0 expected cases), this maintained a highly significant SIR of 3.82 (95% CI 2.92 to 4.90).

also in 132,142 other papers

We also noted that the anti-Mi2 antibody was independently protective against cancer in our adjusted model, while anti-MDA-5 demonstrated a strong trend towards protection that narrowly missed statistical significance.

also in 5,725 other papers